Vigil Neuroscience Statistics
Total Valuation
VIGL has a market cap or net worth of $116.21 million. The enterprise value is $41.80 million.
Important Dates
The last earnings date was Wednesday, May 7, 2025, before market open.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VIGL has 46.67 million shares outstanding. The number of shares has increased by 8.14% in one year.
| Current Share Class | 46.67M |
| Shares Outstanding | 46.67M |
| Shares Change (YoY) | +8.14% |
| Shares Change (QoQ) | +10.59% |
| Owned by Insiders (%) | 0.86% |
| Owned by Institutions (%) | 32.53% |
| Float | 23.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.78 |
| P/TBV Ratio | 1.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.19.
| Current Ratio | 2.97 |
| Quick Ratio | 2.88 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -102.70% and return on invested capital (ROIC) is -58.74%.
| Return on Equity (ROE) | -102.70% |
| Return on Assets (ROA) | -49.38% |
| Return on Invested Capital (ROIC) | -58.74% |
| Return on Capital Employed (ROCE) | -119.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.26M |
| Employee Count | 69 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.26% in the last 52 weeks. The beta is 1.92, so VIGL's price volatility has been higher than the market average.
| Beta (5Y) | 1.92 |
| 52-Week Price Change | -29.26% |
| 50-Day Moving Average | 1.99 |
| 200-Day Moving Average | 2.68 |
| Relative Strength Index (RSI) | 59.63 |
| Average Volume (20 Days) | 149,508 |
Short Selling Information
The latest short interest is 360,669, so 0.77% of the outstanding shares have been sold short.
| Short Interest | 360,669 |
| Short Previous Month | 422,296 |
| Short % of Shares Out | 0.77% |
| Short % of Float | 1.50% |
| Short Ratio (days to cover) | 3.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -91.74M |
| Pretax Income | -82.78M |
| Net Income | -86.73M |
| EBITDA | -91.27M |
| EBIT | -91.74M |
| Earnings Per Share (EPS) | -$2.05 |
Full Income StatementBalance Sheet
The company has $87.10 million in cash and $12.69 million in debt, giving a net cash position of $74.41 million or $1.59 per share.
| Cash & Cash Equivalents | 87.10M |
| Total Debt | 12.69M |
| Net Cash | 74.41M |
| Net Cash Per Share | $1.59 |
| Equity (Book Value) | 65.12M |
| Book Value Per Share | 1.40 |
| Working Capital | 59.75M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$53.24 million and capital expenditures -$290,000, giving a free cash flow of -$53.53 million.
| Operating Cash Flow | -53.24M |
| Capital Expenditures | -290,000 |
| Free Cash Flow | -53.53M |
| FCF Per Share | -$1.15 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |